@Robert Morse.. Here's an example... OPHT, Ophthotech has a very high IV. Dec-16 has an IV of about 420, Jan of 320. They are about to come with some results on their phase 3 trial study, dealbreaker or dealmaker as I'm reading it (@vanzandt you might like this thread
).
So, Spot was around 35, Jan straddle value about $30. The vol curve is relatively flat... although from Interactive Brokers Model IV you could say there still is some skew, I think there's not a lot.
So, let's agree upon the fact risk is to the upside... by the looks of expectancy in options, it seems to at least double in value, possibly triple... anywhere from 70-100?
The 25 put = 8.60 (midpoint), which is 10 dollars/30% OTM.
The 45 call = 11.60, also 10 dollars/30% OTM.
So again, the market prices upside the upside risk.
Now, 25-20 PS = 2.50
the 45-5 CS = 1.50
Both have max value of $5, looking at the upside potential / upside risk... that CS sure looks cheap.
).So, Spot was around 35, Jan straddle value about $30. The vol curve is relatively flat... although from Interactive Brokers Model IV you could say there still is some skew, I think there's not a lot.
So, let's agree upon the fact risk is to the upside... by the looks of expectancy in options, it seems to at least double in value, possibly triple... anywhere from 70-100?
The 25 put = 8.60 (midpoint), which is 10 dollars/30% OTM.
The 45 call = 11.60, also 10 dollars/30% OTM.
So again, the market prices upside the upside risk.
Now, 25-20 PS = 2.50
the 45-5 CS = 1.50
Both have max value of $5, looking at the upside potential / upside risk... that CS sure looks cheap.
